Next-Generation Diabetes Drug Offers the Greatest Growth During Forecast Period
Next Generation Diabetes Therapy and Drug Delivery Market report, published by Allied Market Research, forecasts that the global market was valued at $617 million in 2015 and is expected to garner $9,673 million by 2022, registering a CAGR of 41.1% during the forecast period 2016 - 2023. North America is the highest contributor in the next generation diabetes therapy and drug delivery market; however, Asia-Pacific is witnessing the highest growth rate.
View full press release